A Randomize, Phase 2, Open-Label Study Evaluating

Project: Research project

Project Details

Description

A Randomized, Phase 2, Open-Label Study Evaluating DN24-02 As Adjuvant Therapy In Subjects with High Risk HER2+ Urothelial Carcinoma
StatusActive
Effective start/end date3/3/1112/31/20

Funding

  • DENDREON CORPORATION

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.